Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Jul;41(1):127–128. doi: 10.1136/gut.41.1.127

Iron and hepatitis C.

B R Bacon 1
PMCID: PMC1027241  PMID: 9274485

Full text

PDF
127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton A. L., Banner B. F., Cable E. E., Bonkovsky H. L. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol. 1995 Apr;103(4):419–424. doi: 10.1093/ajcp/103.4.419. [DOI] [PubMed] [Google Scholar]
  2. Caraceni P., Fagiuoli S., Van Thiel D. H. Iron reduction therapy: simply camouflage, or a real weapon? Am J Gastroenterol. 1994 Jul;89(7):970–973. [PubMed] [Google Scholar]
  3. Di Bisceglie A. M., Axiotis C. A., Hoofnagle J. H., Bacon B. R. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992 Jun;102(6):2108–2113. doi: 10.1016/0016-5085(92)90339-z. [DOI] [PubMed] [Google Scholar]
  4. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Jr, Ellis M. C., Fullan A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar]
  5. Hayashi H., Takikawa T., Nishimura N., Yano M., Isomura T., Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994 Jul;89(7):986–988. [PubMed] [Google Scholar]
  6. Lustbader E. D., Hann H. W., Blumberg B. S. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science. 1983 Apr 22;220(4595):423–425. doi: 10.1126/science.6301008. [DOI] [PubMed] [Google Scholar]
  7. Olynyk J. K., Reddy K. R., Di Bisceglie A. M., Jeffers L. J., Parker T. I., Radick J. L., Schiff E. R., Bacon B. R. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology. 1995 Apr;108(4):1104–1109. doi: 10.1016/0016-5085(95)90209-0. [DOI] [PubMed] [Google Scholar]
  8. Piperno A., Sampietro M., D'Alba R., Roffi L., Fargion S., Parma S., Nicoli C., Corbetta N., Pozzi M., Arosio V. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver. 1996 Aug;16(4):248–254. doi: 10.1111/j.1600-0676.1996.tb00737.x. [DOI] [PubMed] [Google Scholar]
  9. Prieto J., Barry M., Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology. 1975 Mar;68(3):525–533. [PubMed] [Google Scholar]
  10. Sutnick A. I., Blumberg B. S., Lustbader E. D. Letter: Elevated serum iron levels and persistent Australia antigen (HBsAG). Ann Intern Med. 1974 Dec;81(6):855–856. doi: 10.7326/0003-4819-81-6-855. [DOI] [PubMed] [Google Scholar]
  11. Van Thiel D. H., Friedlander L., Fagiuoli S., Wright H. I., Irish W., Gavaler J. S. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol. 1994 Mar;20(3):410–415. doi: 10.1016/s0168-8278(94)80017-0. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES